Analysen von James Quigley
| 23.09.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 19.09.24 | Merck Buy | Goldman Sachs Group Inc. | |
| 18.09.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 16.09.24 | Roche Sell | Goldman Sachs Group Inc. | |
| 12.09.24 | Roche Sell | Goldman Sachs Group Inc. | |
| 10.09.24 | Bayer Neutral | Goldman Sachs Group Inc. | |
| 10.09.24 | Roche Sell | Goldman Sachs Group Inc. | |
| 05.09.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
|
Werbung
|
|||
| 02.09.24 | Bayer Neutral | Goldman Sachs Group Inc. | |
| 08.08.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 07.08.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 07.08.24 | Bayer Neutral | Goldman Sachs Group Inc. | |
| 06.08.24 | Bayer Neutral | Goldman Sachs Group Inc. | |
| 05.08.24 | Bayer Neutral | Goldman Sachs Group Inc. | |
| 25.07.24 | Roche Sell | Goldman Sachs Group Inc. | |
| 19.07.24 | Novartis Buy | Goldman Sachs Group Inc. | |
| 19.07.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 18.07.24 | Novartis Buy | Goldman Sachs Group Inc. | |
| 17.07.24 | Bayer Neutral | Goldman Sachs Group Inc. | |
| 17.07.24 | Roche Sell | Goldman Sachs Group Inc. | |
| 15.07.24 | Roche Sell | Goldman Sachs Group Inc. | |
| 11.07.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 08.07.24 | Bayer Neutral | Goldman Sachs Group Inc. | |
| 04.07.24 | Roche Sell | Goldman Sachs Group Inc. | |
| 03.07.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 02.07.24 | Roche Sell | Goldman Sachs Group Inc. | |
| 01.07.24 | Novartis Buy | Goldman Sachs Group Inc. | |
| 27.06.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 17.06.24 | Roche Sell | Goldman Sachs Group Inc. | |
| 05.06.24 | Bayer Neutral | Goldman Sachs Group Inc. | |
| 03.06.24 | Roche Sell | Goldman Sachs Group Inc. | |
| 03.06.24 | Novartis Buy | Goldman Sachs Group Inc. | |
| 30.05.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 30.05.24 | Bayer Neutral | Goldman Sachs Group Inc. | |
| 30.05.24 | Roche Sell | Goldman Sachs Group Inc. | |
| 30.05.24 | Novartis Buy | Goldman Sachs Group Inc. | |
| 30.05.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 30.05.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 21.07.23 | Bayer Equal-weight | Morgan Stanley | |
| 06.01.23 | MorphoSys Underweight | Morgan Stanley | |
| 06.01.23 | Bayer Equal-weight | Morgan Stanley | |
| 06.01.23 | Merck Overweight | Morgan Stanley | |
| 10.08.22 | EVOTEC Underweight | Morgan Stanley | |
| 29.04.22 | EVOTEC Overweight | Morgan Stanley | |
| 25.04.22 | Bayer Overweight | Morgan Stanley | |
| 31.03.22 | Sartorius vz. Overweight | Morgan Stanley | |
| 06.12.21 | EVOTEC Overweight | Morgan Stanley | |
| 12.11.21 | MorphoSys Overweight | Morgan Stanley | |
| 27.10.21 | Merck Equal-weight | Morgan Stanley | |
| 14.07.21 | Bayer Overweight | Morgan Stanley | |